Get the Stockscreener App
2.20
0.92%
0.02
After Hours:
2.21
0.010
+0.45%
Seer Inc stock is traded at $2.20, with a volume of 61,428.
It is up +0.92% in the last 24 hours and up +8.37% over the past month.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
See More
Previous Close:
$2.18
Open:
$2.17
24h Volume:
61,428
Relative Volume:
0.25
Market Cap:
$120.56M
Revenue:
$14.18M
Net Income/Loss:
$-82.66M
P/E Ratio:
-1.6923
EPS:
-1.3
Net Cash Flow:
$-50.80M
1W Performance:
+4.27%
1M Performance:
+8.37%
6M Performance:
-7.95%
1Y Performance:
+6.80%
1-Day Range:
$2.1681
$2.21
1-Week Range:
$2.1008
$2.21
52-Week Range:
$1.585
$2.625
Seer Inc Stock (SEER) Company Profile
Name
Seer Inc
Sector
Industry
Phone
650-453-0000
Address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Compare SEER with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
2.20 | 128.28M | 14.18M | -82.66M | -50.80M | -1.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-04-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-11-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Dec-29-20 | Initiated | BofA Securities | Neutral |
| Dec-29-20 | Initiated | Cowen | Outperform |
| Dec-29-20 | Initiated | JP Morgan | Overweight |
| Dec-29-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Seer Inc Stock (SEER) Latest News
When is the best time to buy Seer Inc. stockPhenomenal wealth increase - jammulinksnews.com
Is Seer Inc. a good long term investmentOverwhelming profit margins - Autocar Professional
Does Seer Inc. stock pay reliable dividendsRapidly expanding wealth - jammulinksnews.com
What drives Seer Inc. stock priceExtraordinary earning power - PrintWeekIndia
What analysts say about Seer Inc. stockExplosive market performance - Autocar Professional
Why Seer Inc. stock attracts strong analyst attentionFree Access to Investors Club - Newser
How Seer Inc. stock performs during market volatilityFree Smart Money Stock Analysis - Newser
What makes Seer Inc. stock price move sharplyBest Stocks for Capital Safety - Newser
Seer Inc. Stock Analysis and ForecastUnprecedented market success - jammulinksnews.com
Seer, Inc. to Announce Second Quarter 2025 Financial Results on August 6, 2025 - Quiver Quantitative
Proteomics Leader Seer Sets Q2 2025 Earnings Call: Key Biotech Results Coming August 6 - Stock Titan
How Seer Inc. stock reacts to Fed policy changesGrowth Optimized Stock Radar - beatles.ru
The Cash Burn Situation: A Closer Look at Seer's (NASDAQ:SEER) - AInvest
Here's Why We're Watching Seer's (NASDAQ:SEER) Cash Burn Situation - Yahoo Finance
Seer Faces Nasdaq Compliance Challenge Following Annual Meeting - AInvest
Seer notifies Nasdaq of audit committee non-compliance, directors elected - Investing.com India
Seer notifies Nasdaq of audit committee non-compliance, directors elected By Investing.com - Investing.com Nigeria
Seer Faces Nasdaq Compliance Challenge After Annual Meeting - TipRanks
Seer (NASDAQ:SEER) Trading 1.4% Higher – Here’s What Happened - Defense World
Seer Launches Sample Study to Develop AI-Driven Cancer Diagnostics for Young Adults - MSN
Strategic Environmental & Energy Resources, Inc. SEC 10-Q Report - TradingView
Insider Sell Alert: Dipchand Nishar Sells 30,253 Shares of Seer Inc (SEER) - GuruFocus
Seer director Nishar Dipchand sells shares worth $62,935 - Investing.com
Seer Inc Stock (SEER) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.97%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):